These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8235341)

  • 41. Aluminum-related osteomalacia: clinical and histological improvement following treatment with desferrioxamine (DFO).
    Rapoport J; Chaimovitz C; Abulfil A; Mostovlavsky M; Gazit D; Bab I
    Isr J Med Sci; 1987 Dec; 23(12):1242-6. PubMed ID: 3440748
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Do serum aluminum levels reflect underlying skeletal aluminum accumulation and bone histology before or after chelation by deferoxamine?
    Hodsman AB; Hood SA; Brown P; Cordy PE
    J Lab Clin Med; 1985 Dec; 106(6):674-81. PubMed ID: 4067379
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aluminum accumulation in children on chronic dialysis: predictive value of serum aluminum levels and desferrioxamine infusion test.
    Roodhooft AM; van de Vyver FL; D'Haese PC; van Acker KJ; Visser WJ; de Broe ME
    Clin Nephrol; 1987 Sep; 28(3):125-9. PubMed ID: 3665205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improvement of anaemia with desferrioxamine in haemodialysis patients.
    Praga M; Andrés A; de la Serna J; Ruilope LM; Nieto J; Estenoz J; Millet VG; Arnaiz F; Rodicio JL
    Nephrol Dial Transplant; 1987; 2(4):243-7. PubMed ID: 3118265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [A case of iron and aluminum related osteomalacia in a long-term hemodialysis patient].
    Yamagata K; Kobayashi M; Koyama A; Narita M; Amagai H; Ohno A; Yoshikawa S
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):437-42. PubMed ID: 1875564
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J; Wilhelm M; Busch T; Grabensee B; Ohnesorge FK
    Dtsch Med Wochenschr; 1989 Feb; 114(7):253-7. PubMed ID: 2917487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS; Hercz G; Miller JH; Shinaberger JH; Nissenson AR; Coburn JW
    Kidney Int Suppl; 1986 Feb; 18():S100-3. PubMed ID: 3457984
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparison of the effectiveness of hemodialysis and hemofiltration in the removal of aluminum from the body].
    Sulková S; Laurincová Z; Pancírová J; Komonová D; Válek A
    Cas Lek Cesk; 1990 Aug; 129(32):998-1001. PubMed ID: 2208242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperaluminemia associated with liver transplantation and acute renal failure.
    Erasmus RT; Kusnir J; Stevenson WC; Lobo P; Herman MM; Wills MR; Savory J
    Clin Transplant; 1995 Aug; 9(4):307-11. PubMed ID: 7579738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Osteomalacia as a result of aluminum poisoning during chronic hemodialysis].
    Cournot-Witmer G; Gagnadoux MF; Lebon P; Broyer M; Balsan S
    Arch Fr Pediatr; 1982 Dec; 39 Suppl 2():749-54. PubMed ID: 6762177
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Aluminum poisoning in renal dialysis patients: bone histology. Value of quantitative bone biopsy].
    Charhon SA; Chapuy MC; Traeger J; Meunier PJ
    Presse Med; 1984 Jun; 13(23):1431-4. PubMed ID: 6233588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aluminium-related bone disease and haemodialysis.
    Seyfert UT; Didion K; Albert FW
    Lancet; 1987 Aug; 2(8556):456. PubMed ID: 2887758
    [No Abstract]   [Full Text] [Related]  

  • 53. [The role of aluminum in the human body].
    Strzałkowska D
    Postepy Hig Med Dosw; 1991; 45(3-4):257-79. PubMed ID: 1946095
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of dialysis osteomalacia with desferrioxamine.
    Brown DJ; Dawborn JK; Ham KN; Xipell JM
    Lancet; 1982 Aug; 2(8294):343-5. PubMed ID: 6124756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Deferoxamine for aluminum toxicity in dialysis patients.
    Hernandez P; Johnson CA
    ANNA J; 1990 Jun; 17(3):224-8. PubMed ID: 2357118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature].
    Seidowsky A; Dupuis E; Drueke T; Dard S; Massy ZA; Canaud B
    Nephrol Ther; 2018 Feb; 14(1):35-41. PubMed ID: 29174672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis.
    Charhon SA; Chavassieux PM; Meunier PJ; Accominotti M
    Br Med J (Clin Res Ed); 1985 Jun; 290(6482):1613-4. PubMed ID: 3924189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fracture healing with deferoxamine therapy in a patient with aluminum-associated osteomalacia.
    Phelps KR; Einhorn TA; Vigorita VJ; Lundin AP; Friedman EA
    ASAIO Trans; 1986; 32(1):198-200. PubMed ID: 3778712
    [No Abstract]   [Full Text] [Related]  

  • 59. The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure.
    Malluche HH; Smith AJ; Abreo K; Faugere MC
    N Engl J Med; 1984 Jul; 311(3):140-4. PubMed ID: 6377067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of aluminum-induced osteopathy with desferrioxamine in dialysis-dependent renal failure].
    Lechleitner P; Gmeiner R; Beck G; König P
    Wien Med Wochenschr; 1987 Aug; 137(14-15):355-60. PubMed ID: 3673100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.